26 / 160
578
REFERENCIAS BIBLIOGRáFICAS
1.
Warren JR, Marshall BJ, Unidentiffied curved bacilli on gastric
epithelium in active chronic gastritis Lancet 1983; 321: 1273-5
2. A. Rollan et als.. Management of Helicobacter pylori in Latin
America: A Delphi technique-based consensus. World J
Gastroenterol, Aug 21, 2014; 20 (31) 10969-10983.
3. Kenshi Yao. The endoscopic diagnosis of early gastric cancer
Annals of Gastroenterology, Volume 26, No 1 (2013) Fukuoka
University Chikushi Hospital, Japan.
4. Peleteiro B, Bustos A, Ferro A, Lunet N. Prevalence of Helicobacter
pylori infection worldwide: a systematic review of studies with
National coverage. Dig Dis Sci 2014 Aug 59 (8) 1698-709.
5. L. Gatta, N. Vakil, D. Vaina and Scarpignato C. Global eradication
rates for Helicobacter pylori infection: systematic Review and
Meta-analysis of sequential therapy. BMJ 2013, 347; f 4587.
6. Dos Santos AA, Carvalho AA, Pharmacological therapy used in
the elimination of Helicobacter pylori infection: A review. World J
Gastroenterol 2015 Jan 7; 21 (1): 139-154.
7. Yuhong Yuan, Alex Ford, Khurrm J Kahn, Xavier Gisbert et
al. Optimum duration of regimens for Helicobacter pylori
eradication. The Cochrane Library. Published on line. 11Dec
2013.
8. Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY et al. Concomitant
therapy achieved the best eradication rate for Helicobacter pylori,
among various treatment strategies. World J Gastroenterol 2015
Jan 7;21 (1) 351-9.
9. Coelho LG, Leon Barua R, Quigley EM. Latin-American Consensus
Conference on Helicobacter pylori infection. Latin-American
National Gastroenterological Societies affiliated with the
inter-American Association of Gastroenterology (AIGE) Am J
Gastroenterol. 2000; 95 :2688-91.
10. Graham DY, Fischbach L. Helicobacter pylori treatment in the
era of increasing antibiotic resistance. Gut, 2010 Aug; 59(8):
1143-53.
11. Overland MK. Dyspepsia. Med Clin North Am 2014 May. 98(3)
549-64.
12. Wee EW, Evidence based approach to dyspepsia: from
Helicobacter pylori to functional disease. Postgrad Med 2013
Jul; 125(4):169-80.
13. Alexander C. Ford, David Forman, Richard Hunt, Yuhong Yuan,
Paul Moayyedi. Helicobacter pylori erradication therapy to
prevent gastric cancer in healthy asymptomatic infected
individuals: Systematic review and meta-analysis of randomized
controlled trials. BMJ 2014; 348 q 3174.
14. Malfertheiner P, Megraud F, O’Morain CA, et al European
Helicobacter Study Group. Management of Helicobacter pylori
infection- the Maastricht IV/ Florence Consensus Report. Gut
2012 May; 61 (5): 646-64 (44 collaborators/24 countries).
15. Moyyedi P, Hunt R, Forman D, Helocobacter pylori eradication for
the prevention of gastric neoplasm.
Cochrane Database Syst Rev (2006) CD 005583.
16. Ford AC, Forman D, Hunt RH, Yuan Y Moayyedi P. Helicobacter
pylori eradication therapy to prevent gastric cancer in healthy
asymptomatic infected individuals: systematic review and
meta-analysis of randomized controlled trials. BMJ. 2014 May,
20, 348: g 3174.
17. Correa P. The Gastric precancerous process. Cancer Surv 1983;
2:437-50.
18. Yuhong Yuan, Alex C Ford, Khurram J Kahn, Javier P Gisbert,
David Forman, Grigorios I Leontiadis, et al.
Optimum duration of regimens for Helicobacter pylori
eradication. Editorial Group: Cochrane Upper Gastrointestinal
and pancreatic Disease Group. On line Dec 2013.
19. Ma JL, Zhang L, Brown LM, Li JY et al. Fifteen-year effects of
Helicobacter pylori, garlic, and vitamin treatments on gastric
cancer incidence and mortality. J Natl Cancer Inst, 2012; 104:
488-492.
[REV. MED. CLIN. CONDES - 2015; 26(5) 572-578]